Volume 57, Issue 12 pp. 1893-1898
Original Article

Retrospective review of Kawasaki disease at the Women's and Children's Hospital, South Australia

Hannah Davidson

Corresponding Author

Hannah Davidson

Department of Cardiology, Women's and Children's Hospital, Adelaide, South Australia, Australia

Correspondence: Dr Hannah Davidson, The Heart Centre for Children, The Children's Hospital Westmead Cnr Hawkesbury Road and Hainsworth Street, Westmead, NSW 2145, Australia. Fax: 0298452163; email: [email protected]

Search for more papers by this author
Andrew Kelly

Andrew Kelly

Department of Cardiology, Women's and Children's Hospital, Adelaide, South Australia, Australia

Faculty of Health and Medical Sciences, Department of Paediatrics Adelaide, The University of Adelaide, Adelaide, South Australia, Australia

Search for more papers by this author
Rishi Agrawal

Rishi Agrawal

Faculty of Health and Medical Sciences, Department of Paediatrics Adelaide, The University of Adelaide, Adelaide, South Australia, Australia

Department of General Paediatric Medicine, Women's and Children's Hospital, Adelaide, South Australia, Australia

Search for more papers by this author
First published: 01 June 2021
Citations: 1

Conflict of interest: None declared.

Abstract

Aim

Kawasaki disease (KD) is one of the most common causes of acquired cardiac disease in children in high-income countries. The incidence of coronary artery disease (CAD), despite treatment with intravenous immunoglobulin, ranges from 5 to 20%. Determining risk factors for CAD may assist with management and reduce long-term complications.

Methods

Retrospective data were collected for all patients presenting to the Women's and Children's Hospital with a discharge diagnosis of KD over a 10.5-year period, from 2007 to 2018.

Results

A total of 141 patients were included in the review; 101 patients fulfilled complete criteria for KD; 25 incomplete criteria and 15 did not meet criteria but were treated for KD. CAD was present in 27.7% of all patients, ranging from ectasia to giant aneurysms based on Z-scores and echocardiogram descriptions. Medium to large aneurysms accounted for 8.5% of all patients with suspected KD. Patients with CAD were more likely to: fulfil incomplete criteria (odds ratio (OR) 4.3, 95% confidence interval (CI) 1.7–10.8, P = 0.0027), be less than 12 months of age (OR 11.38, 95% CI 2.94–44.11, P = 0.0001), have CRP > 100 (OR 2.8, 95% CI 1.31–6.02, P = 0.0068) and have a delay in treatment (average day of illness prior to treatment 8.89 vs. 6.78 (OR 1.19, 95% CI 1.05–1.35, P = 0.0055)). Patients with a Kobayashi score ≥4 had a higher rate of re-treatment with intravenous immunoglobulin (OR 3.16, 95% CI 1.27–7.83, P = 0.013).

Conclusion

Our data are consistent with previously reported risk factors, and high rates of CAD despite standard treatment.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.